𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents

✍ Scribed by A Kadiri; A Chraibi; F Marouan; M.R Ababou; N El Guermai; A Wadjinny; A Kerfati; M Douiri; J.D Bensouda; J Belkhadir; Y Arvanitis

Book ID
117371522
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
317 KB
Volume
41
Category
Article
ISSN
0168-8227

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of the combination of insulin an
Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents
✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. TΓΆtterman; F. Fyhrqvist; L. Groop πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa

Antibodies to Glutamic Acid Decarboxylas
Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy
✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Effects of a combination of bedtime inte
Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents
✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months